Table of Contents Author Guidelines Submit a Manuscript
Journal of Tropical Medicine
Volume 2012, Article ID 651927, 8 pages
http://dx.doi.org/10.1155/2012/651927
Review Article

A Quality Management Approach to Implementing Point-of-Care Technologies for HIV Diagnosis and Monitoring in Sub-Saharan Africa

1Clinical Monitoring Research Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, MD 21702, USA
2Rakai Health Sciences Program, Uganda Virus Research Institute, Kalisizo, Uganda
3Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

Received 14 July 2011; Revised 24 October 2011; Accepted 26 October 2011

Academic Editor: John Waitumbi

Copyright © 2012 Joseph P. Shott et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Kates, E. Lief, and C. Avila, Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance From the G8, European Commission and Other Donor Governments in 2008, Kaiser Family Foundation, Menlo Park, Calif, USA, 2009.
  2. J. O. Westgard, “A method evaluation decisionchart for judging method performance,” Clinical Laboratory Science, vol. 8, no. 5, pp. 277–283, 1995. View at Google Scholar · View at Scopus
  3. L. A. Spacek, F. Lutwama, H. M. Shihab et al., “Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, Uganda,” International Journal of STD and AIDS, vol. 22, no. 6, pp. 310–314, 2011. View at Publisher · View at Google Scholar
  4. G. G. Sherman, P. A. Cooper, A. H. Coovadia et al., “Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings,” Pediatric Infectious Disease Journal, vol. 24, no. 11, pp. 993–997, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Emery, S. Bodrug, B. A. Richardson et al., “Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya,” Journal of Clinical Microbiology, vol. 38, no. 7, pp. 2688–2695, 2000. View at Google Scholar · View at Scopus
  6. J. A. Crump, L. E. Scott, E. Msuya et al., “Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa,” Journal of Virological Methods, vol. 162, no. 1-2, pp. 218–222, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. R. G. Downing, R. A. Otten, E. Marum et al., “Optimizing the delivery of HIV counseling and testing services: the Uganda experience using rapid HIV antibody test algorithms,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 18, no. 4, pp. 384–388, 1998. View at Google Scholar · View at Scopus
  8. I. M. Malonza, B. A. Richardson, J. K. Kreiss, J. J. Bwayo, and G. C. J. Stewart, “The effect of rapid HIV-1 testing on uptake of perinatal HIV-1 interventions: a randomized clinical trial,” AIDS, vol. 17, no. 1, pp. 113–118, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. S. C. Kagulire, P. D. Stamper, P. Opendi et al., “Performance of two commercial immunochromatographic assays for rapid detection of antibodies specific to human immunodeficiency virus types 1 and 2 in serum and urine samples in a rural community-based research setting (Rakai, Uganda),” Clinical and Vaccine Immunology, vol. 14, no. 6, pp. 738–740, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Taye, Y. Woldeamanuel, and E. Kebede, “Diagnostic detection of human immunodeficincy virus type-1 antibodies in urine, Jimma Hospital, South West Ethiopa,” Ethiopian Medical Journal, vol. 44, no. 4, pp. 363–368, 2006. View at Google Scholar · View at Scopus
  11. S. J. S. Pascoe, L. F. Langhaug, J. Mudzori, E. Burke, R. Hayes, and F. M. Cowan, “Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural Zimbabwe,” AIDS Patient Care and STDs, vol. 23, no. 7, pp. 571–576, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. R. L. Hamers, I. H. de Beer, H. Kaura, M. van Vugt, L. Caparos, and T. F. de Wit, “Diagnostic accuracy of 2 oral fluid-based tests for HIV surveillance in Namibia,” Journal of Acquired Immune Deficiency Syndromes, vol. 48, no. 1, pp. 116–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. B. S. Parekh, M. B. Kalou, G. Alemnji, C. Y. Ou, G. M. Gershy-Damet, and J. N. Nkengasong, “Scaling up HIV rapid testing in developing countries: comprehensive approach for implementing quality assurance,” American Journal of Clinical Pathology, vol. 134, no. 4, pp. 573–584, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Zeh, B. Oyaro, H. Vandenhoudt et al., “Performance of six commercial enzyme immunoassays and two alterantive HIV-testing algorithms for the diagnosis of HIV-1 infection in Kisumu, Western Kenya,” Journal of Virological Methods, vol. 176, no. 1-2, pp. 24–31, 2011. View at Publisher · View at Google Scholar
  15. R. H. Gray, F. Makumbi, D. Serwadda et al., “Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study,” British Medical Journal, vol. 335, no. 7612, pp. 188–190, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. S. C. Kagulire, P. Opendi, P. D. Stamper et al., “Field evaluation of five rapid diagnostic tests for screening of HIV-1 infections in rural Rakai, Uganda,” International Journal of STD and AIDS, vol. 22, no. 6, pp. 308–309, 2011. View at Publisher · View at Google Scholar
  17. D. B. Klarkowski, J. M. Wazome, K. M. Lokuge, L. Shanks, C. F. Mills, and D. P. O'Brien, “The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm,” PLoS ONE, vol. 4, no. 2, Article ID e4351, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. http://www.cdc.gov/hiv/topics/testing/rapid/rt-comparison.htm. Accessed June 16, 2011.
  19. USAID Bureau for Global Health, http://www.usaid.gov/our_work/global_health/aids/TechAreas/treatment/scms.html#resources. Accessed June 16, 2011.
  20. FDA Consumer Report, http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm216409.htm. (Accessed 14 Oct 2011).
  21. World Health Organization, Department of Health and Human Services, and Centers for Disease Control and Prevention, Guidelines for Assuring the Accuracy and Reliability of HIV Rapid Testing: Applying a Quality System Approach, World Health Organization, Geneva, Switzerland, 2005.
  22. S. J. Reynolds, L. M. Ndongala, C. C. Luo et al., “Evaluation of a rapid test for the detection of antibodies to human immunodeficiency virus type 1 and 2 in the setting of multiple transmitted viral subtypes,” International Journal of STD and AIDS, vol. 13, no. 3, pp. 171–173, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Dessie, B. Abera, F. Walle, D. Wolday, and W. Tamene, “Evaluation of determine HIV-1/2 rapid diagnostic test by 4th generation ELISA using blood donors' serum at Felege Hiwot Referral Hospital, Northwest Ethiopia,” Ethiopian Medical Journal, vol. 46, no. 1, pp. 1–5, 2008. View at Google Scholar · View at Scopus
  24. A. F. Aghokeng, L. Ewane, B. Awazi et al., “Evaluation of four simple/rapid assays and two fourth-generation ELISAs for the identification of HIV infection on a serum panel representing the HIV-1 group M genetic diversity in Cameroon,” Journal of Acquired Immune Deficiency Syndromes, vol. 37, no. 5, pp. 1632–1640, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. US PEPFAR, http://www.pepfar.gov/results/index.htm. Accessed June 16, 2011.
  26. C. W. Dieffenbach and A. S. Fauci, “Thirty years of HIV and AIDS: future challenges and opportunities,” Annals of Internal Medicine, vol. 154, no. 11, pp. 766–771, 2011. View at Google Scholar
  27. J. J. G. van Oosterhout, L. Brown, R. Weigel et al., “Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria,” Tropical Medicine and International Health, vol. 14, no. 8, pp. 856–861, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Mee, K. L. Fielding, S. Charalambous, G. J. Churchyard, and A. D. Grant, “Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa,” AIDS, vol. 22, no. 15, pp. 1971–1977, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. L. A. Spacek, R. H. Gray, M. J. Wawer et al., “Clinical illness as a marker for initiation of HIV antiretroviral therapy in a rural setting, Rakai, Uganda,” International Journal of STD and AIDS, vol. 17, no. 2, pp. 116–120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Meya, L. A. Spacek, H. Tibenderana et al., “Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria,” Journal of the International AIDS Society, vol. 12, no. 3, pp. 1–10, 2009. View at Google Scholar
  31. WHO/UNAIDS, Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach. 2010 rev.
  32. US CDC, Guidelines for treating HIV-infected infants, children, and adolescents; including information on clinical monitoring, initiation of treatment, pediatric-specific drug information, and managing complications. 2010 rev.
  33. S. Mtapuri-Zinyowera, M. Chideme, D. Mangwanya et al., “Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe,” JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 55, no. 1, pp. 1–7, 2010. View at Google Scholar · View at Scopus
  34. I. V. Jani, N. E. Sitoe, P. L. Chongo et al., “Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing,” AIDS, vol. 25, no. 6, pp. 807–812, 2011. View at Publisher · View at Google Scholar
  35. N. van Shaik, K. Kranzer, L. Myer et al., “Field validation of the PIMA analyzer in a mobile clinic setting in South Africa. [poster #V-144],” in Proceedings of the Retroviruses and Opportunistic Infections Conference, February 2010.
  36. C. C. Moore, S. T. Jacob, R. Pinkerton et al., “Point-of-care lactate testing predicts mortality of severe sepsis in a predominantly HIV type 1-infected patient population in Uganda,” Clinical Infectious Diseases, vol. 46, no. 2, pp. 215–222, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. A. K. Kiragga, P. Ocama, S. J. Reynolds, A. Kambugu, H. Ojiambo, and B. Castelnuovo, “Validation of a portable hand-held lactate analyzer for determination of blood lactate in patients on antiretroviral therapy in Uganda,” Journal of Acquired Immune Deficiency Syndromes, vol. 49, no. 5, pp. 564–566, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. L. A. Mills, J. Kagaayi, G. Nakigozi et al., “Utility of a point-of-care malaria rapid diagnostic test for excluding malaria as the cause of fever among HIV-positive adults in Rural Rakai, Uganda,” American Journal of Tropical Medicine and Hygiene, vol. 82, no. 1, pp. 145–147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Brahmbhatt, D. Sullivan, G. Kigozi et al., “Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality,” Journal of Acquired Immune Deficiency Syndromes, vol. 47, no. 4, pp. 472–478, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. Foundation for Innovative and Novel Diagnostics, http://www.finddiagnostics.org/programs/tb/tb_diagnostics.html. Accessed June 16, 2011.
  41. R. Mutetwa, C. Boehma, M. Dimairo et al., “Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberulosis suspects and patients,” International Journal of Tuberculosis and Lung Disease, vol. 13, no. 10, pp. 1253–1259, 2009. View at Google Scholar
  42. C. Boehme, E. Molokova, F. Minja et al., “Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 99, no. 12, pp. 893–900, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Kunnath-Velayudhan, H. Salamon, H. Y. Wang et al., “Dynamic antibody responses to the Mycobacterium tuberculosis proteome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 33, pp. 14703–14708, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. S. J. Reynoids, G. Nakigozi, K. Newell et al., “Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda,” AIDS, vol. 23, no. 6, pp. 697–700, 2009. View at Publisher · View at Google Scholar · View at Scopus